(19)
(11) EP 4 164 750 A1

(12)

(43) Date of publication:
19.04.2023 Bulletin 2023/16

(21) Application number: 20940284.1

(22) Date of filing: 11.06.2020
(51) International Patent Classification (IPC): 
A61P 35/00(2006.01)
C07K 14/705(2006.01)
A61P 37/02(2006.01)
C07K 16/44(2006.01)
A61K 39/39(2006.01)
A61P 35/02(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 35/00; A61P 35/02; A61P 37/02; C07K 16/44; C07K 14/70575; C07K 14/70532; C07K 14/535; C07K 14/475; C07K 2319/00; C07K 2319/02; C07K 2319/03; C07K 14/7151; C07K 2317/622; C07K 2317/72; A61K 2039/5152; A61K 2039/5156; A61K 39/0011; C12N 2740/16043
(86) International application number:
PCT/US2020/037283
(87) International publication number:
WO 2021/251975 (16.12.2021 Gazette 2021/50)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(71) Applicant: Alloplex Biotherapeutics
Woburn, MA 01801 (US)

(72) Inventor:
  • BORRIELLO, Frank
    Winchester, MA 01890 (US)

(74) Representative: J A Kemp LLP 
80 Turnmill Street
London EC1M 5QU
London EC1M 5QU (GB)

   


(54) ALLOGENEIC TUMOR CELL VACCINE